The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal ... "It offers the potential to detect colorectal cancer in a person who is non-adherent ...

The Food and Drug Administration approved a blood test intended to detect colorectal cancer on Monday ... risk and not experiencing symptoms. "The FDA approval of the Shield test is a significant ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

The blood test, known as Shield and manufactured by Guardant Health, is already commercially available, but FDA approval ... improve colorectal cancer screening rates so we can detect more cancers ...

Shield is the first FDA-approved blood test for primary colorectal ... that would use blood samples to detect colorectal cancers. The device detects a colon cancer secreted protein known as ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, published May 22 in Cancer Discovery, researchers at Johns Hopkins ...

While the previous PATHFINDER study—a prospective, year-long examination of about 6,600 people—showed that Galleri could more ...

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

Freenome has published data in JAMA from the pivotal trial of its blood-based test for colorectal cancer. The paper, which Freenome published Monday, contains similar key findings as the company’s ...